KV Pharmaceutical Co. Mergers & Acquisitions

KV Pharmaceutical Co. M&A Summary

KV Pharmaceutical Co. has acquired 1 company. It has also divested 1 asset.

KV Pharmaceutical Co.’s largest acquisition to date was in 2008, when it acquired Hologic - Gestiva for $82M. It’s largest disclosed sale occurred in 2009, when it sold KV Pharmaceutical - ANDA to Perrigo Company for $14M. KV Pharmaceutical Co. has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity1
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 2

KV Pharmaceutical Co.

16640 Chesterfield Grove Road Suite 200,
Chesterfield, Missouri 63005
United States,
(314) 645-6600
www.kvpharmaceutical.com

All (2) Buy (1) Sell (1)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2009-09-21 KV Pharmaceutical - ANDA · Medical Products
Chesterfield, Missouri

KV Pharmaceutical - ANDA comprises clindamycin phosphate (1%) and benzoyl peroxide (5%) gel. Duac gel, indicated for the topical treatment of inflammatory acne vulgaris.

Revenue (mlns) 165 USD
14
0.1x REVENUE
Divestiture

Perrigo Company

KV Pharmaceutical Co.


Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.